Search
for
Sort by
Research 241–270 of 1000+
- Cutaneous adverse effects of targeted therapies
- A Hot New Twist to Hair Biology
- Acne: Hormonal concepts and therapy
- Endocrine control of benign prostatic hyperplasia
- A Novel Point Mutation in the Ligand-Binding Domain (LBD) of the Human Glucocorticoid Receptor (hGR) Causing Generalized Glucocorticoid Resistance: The Importance of the C Terminus of hGR LBD in Conferring Transactivational Activity
- Acne
- Short-Chain Fatty Acids from <i>Cutibacterium acnes</i> Activate Both a Canonical and Epigenetic Inflammatory Response in Human Sebocytes
- Fulvestrant, a new treatment option for advanced breast cancer: tolerability versus existing agents
- Clinical biochemistry of dihydrotestosterone
- The evolutionary impact of androgen levels on prostate cancer in a multi-scale mathematical model
- Idiopathic Hirsutism*
- Intracrine and Myotrophic Roles of 5α-Reductase and Androgens
- Fatal Toxic Epidermal Necrolysis Associated With Cetuximab in a Patient With Colon Cancer
- Neurosteroids Are Endogenous Neuroprotectants in an Ex Vivo Glaucoma Model
- In Vitro Main Pathways of Steroid Action in Cultured Hair Follicle Cells: Vascular Approach
- Pharmacological Approaches to Controlling Cardiometabolic Risk in Women with PCOS
- Activation of AR Sensitizes Breast Carcinomas to NVP-BEZ235's Therapeutic Effect Mediated by PTEN and KLLN Upregulation
- Androgenic disorders of women: Diagnostic and therapeutic decision making
- Cutaneous Manifestations in Biological-Treated Inflammatory Bowel Disease Patients: A Narrative Review
- Novel Uses for the Anabolic Androgenic Steroids Nandrolone and Oxandrolone in the Management of Male Health
- Emerging drugs for hypogonadism
- Treatment of androgen excess in females: Yesterday, today and tomorrow
- JAK-STAT1 as therapeutic target for EGFR deficiency-associated inflammation and scarring alopecia
- Chapter 23. Therapeutic Control of Androgen Action
- Plants as potential active components in treatment of androgenetic alopecia
- Cardiovascular profile of pharmacological agents used for the management of polycystic ovary syndrome
- Medikamentöse Therapie der BPH Ist eine Kombinationstherapie mit 5α-Reduktasehemmern und α-Rezeptorenblockern sinnvoll?
- Human scalp hair: Modulation by various factors and hormones do estrogens inhibit or stimulate—A perplexing perspective
- Steroid Hormones
- Cost-effective therapy in patients with idiopathic hirsutism